Note 6 - Share-Based Compensation

6 Months Ended

Dec. 31, 2019

Notes to Financial Statements

Share-based Payment Arrangement [Text Block]

6. Share-Based Compensation

The following table presents the share-based compensation expense recognized for stock-based options during the

three

months ended

December 31, 2019 

and

2018

 (in thousands): 

	Three Months ended December 31,
	2019		2018
Cost of sales	$	8	$	10
Research and development expenses		19		18
Sales and marketing expenses		24		22
General and administrative expenses		43		47
Total share-based compensation	$	94	$	97

The following table presents the share-based compensation expense recognized for stock-based options during the

six

months ended

December 31, 2019 

and

2018

 (in thousands): 

	Six Months ended December 31,
	2019		2018
Cost of sales	$	16	$	20
Research and development expenses		38		36
Sales and marketing expenses		49		44
General and administrative expenses		82		90
Total share-based compensation	$	185	$	190

As of

December 31, 2019,

total unrecognized compensation expense related to stock-based options was approximately

$454,000

and the related weighted-average period over which it is expected to be recognized is approximately

.91

 years.

A summary of stock options within the Company’s share-based compensation plans as of

December 31, 2019 

was as follows (in thousands except for exercise prices and terms):

					Weighted
			Weighted		Average
	Number of		Exercise		Contractual		Intrinsic
As of December 31, 2019	Options		Price		Term (Years)		Value
Outstanding		4,651	$	.64		7.46	$	418
Vested and expected to vest		4,651	$	.64		7.46	$	418
Vested and exercisable		2,956	$	.74		6.71	$	172

There were

no

stock options exercised during the

three

months ended

December 31, 2019 

and

2018,

respectively. The Company’s current policy is to issue new shares to satisfy stock option exercises.

There were

30,000

and

155,000

option awards granted with a fair value of approximately

$11,000

and

$52,000

during the

three

months ended

December 31, 2019 

and

2018,

respectively.

There were

no

stock option awards which expired during the

three

months ended

December 31, 2019 

and

2018,

respectively.

There were

no

and

32,000

stock option awards forfeited during the

three

months ended

December 31, 2019 

and

2018,

respectively.

There were

no

stock options exercised during the 

six

months ended

December 31, 2019 

and

2018,

respectively. The Company’s current policy is to issue new shares to satisfy stock option exercises.

There were 

40,000

and

237,500

option awards granted with a fair value of approximately

$14,000

and

$87,000

during the

six

months ended

December 31, 2019 

and

2018,

respectively.

There were

8,250

 and

10,000

stock option awards which expired during the

six

months ended

December 31, 2019 

and

2018,

respectively.

There were

26,250

and

70,750

stock option awards forfeited during the

six

months ended

December 31, 2019 

and

2018,

respectively.